Literature DB >> 31709771

2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis.

Claire E H Barber1, JoAnn Zell2, Jinoos Yazdany3, Aileen M Davis4, Laura Cappelli5, Linda Ehrlich-Jones6, Donna Everix7, J Carter Thorne8, Victoria Bohm1, Lisa Suter9, Alex Limanni10, Kaleb Michaud11.   

Abstract

OBJECTIVE: To develop American College of Rheumatology (ACR) recommendations for patient-reported Functional Status Assessment Measures (FSAMs) for use in routine clinical practice in patients with rheumatoid arthritis (RA).
METHODS: We convened a workgroup to conduct a systematic review of published literature through March 16, 2017 and abstract FSAM properties. Based upon initial search results and clinical input, we focused on the following FSAMs appropriate for routine clinical use: the Health Assessment Questionnaire (HAQ) and derived measures and the Patient-Reported Outcomes Measurement Information System (PROMIS) tool. We used the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) 4-point scoring method to evaluate each FSAM, allowing for overall level of evidence assessment. We identified FSAMs fulfilling a predefined minimum standard and, through a modified Delphi process, selected preferred FSAMs for regular use in most clinic settings.
RESULTS: The search identified 11,835 articles, of which 56 were included in the review. Descriptions of the measures, properties, study quality, level of evidence, and feasibility were abstracted and scored. Following a modified Delphi process, 7 measures fulfilled the minimum standard for regular use in most clinic settings, and 3 measures were recommended: the PROMIS physical function 10-item short form (PROMIS PF10a), the HAQ-II, and the Multidimensional HAQ.
CONCLUSION: This work establishes ACR recommendations for preferred RA FSAMs for regular use in most clinic settings. These results will inform clinical practice and can support future ACR quality measure development as well as highlight ongoing research needs.
© 2019, American College of Rheumatology.

Entities:  

Mesh:

Year:  2019        PMID: 31709771      PMCID: PMC6884654          DOI: 10.1002/acr.24040

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  44 in total

1.  Linking health-status measurements to the international classification of functioning, disability and health.

Authors:  Alarcos Cieza; Thomas Brockow; Thomas Ewert; Edda Amman; Barbara Kollerits; Somnath Chatterji; T Berdihan Ustün; Gerold Stucki
Journal:  J Rehabil Med       Date:  2002-09       Impact factor: 2.912

2.  ICF linking rules: an update based on lessons learned.

Authors:  Alarcos Cieza; Szilvia Geyh; Somnath Chatterji; Nenad Kostanjsek; Bedirhan Ustün; Gerold Stucki
Journal:  J Rehabil Med       Date:  2005-07       Impact factor: 2.912

Review 3.  Measurement properties of performance-based measures to assess physical function in hip and knee osteoarthritis: a systematic review.

Authors:  F Dobson; R S Hinman; M Hall; C B Terwee; E M Roos; K L Bennell
Journal:  Osteoarthritis Cartilage       Date:  2012-08-31       Impact factor: 6.576

4.  Validation of single-factor structure and scoring protocol for the Health Assessment Questionnaire-Disability Index.

Authors:  Jason C Cole; Sarosh J Motivala; Dinesh Khanna; Jessica Y Lee; Harold E Paulus; Michael R Irwin
Journal:  Arthritis Rheum       Date:  2005-08-15

5.  Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory.

Authors:  James F Fries; Eswar Krishnan; Matthias Rose; Bharathi Lingala; Bonnie Bruce
Journal:  Arthritis Res Ther       Date:  2011-09-14       Impact factor: 5.156

6.  Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis.

Authors:  Jean-David Cohen; Maxime Dougados; Philippe Goupille; Alain Cantagrel; Olivier Meyer; Jean Sibilia; Jean-Pierre Daurès; Bernard Combe
Journal:  J Rheumatol       Date:  2006-08-15       Impact factor: 4.666

7.  Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format.

Authors:  T Pincus; C Swearingen; F Wolfe
Journal:  Arthritis Rheum       Date:  1999-10

8.  PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.

Authors:  Karon F Cook; Sally E Jensen; Benjamin D Schalet; Jennifer L Beaumont; Dagmar Amtmann; Susan Czajkowski; Darren A Dewalt; James F Fries; Paul A Pilkonis; Bryce B Reeve; Arthur A Stone; Kevin P Weinfurt; David Cella
Journal:  J Clin Epidemiol       Date:  2016-03-04       Impact factor: 6.437

9.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02

10.  Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis.

Authors:  Jos Hendrikx; Marieke J de Jonge; Jaap Fransen; Wietske Kievit; Piet Lcm van Riel
Journal:  RMD Open       Date:  2016-08-18
View more
  9 in total

1.  Development of an interdisciplinary early rheumatoid arthritis care pathway.

Authors:  Xenia Gukova; Glen S Hazlewood; Hector Arbillaga; Paul MacMullan; Gabrielle L Zimmermann; Cheryl Barnabe; May Y Choi; Megan R W Barber; Alexandra Charlton; Becky Job; Kelly Osinski; Nicole M S Hartfeld; Marlene W Knott; Paris Pirani; Claire E H Barber
Journal:  BMC Rheumatol       Date:  2022-06-25

2.  Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic Arthritis.

Authors:  Ying Ying Leung; Ana-Maria Orbai; Alexis Ogdie; Pil Hojgaard; Richard Holland; Niti Goel; Jeffrey Chau; Laura C Coates; Vibeke Strand; Dafna D Gladman; Philip J Mease; Robin Christensen; William Tillett
Journal:  J Rheumatol       Date:  2020-02-01       Impact factor: 5.346

3.  Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits.

Authors:  Bryant R England; Claire E H Barber; Martin Bergman; Veena K Ranganath; Lisa G Suter; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12       Impact factor: 5.178

4.  Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis.

Authors:  Lucy H Liu; Sarah B Garrett; Jing Li; Dana Ragouzeos; Beth Berrean; Daniel Dohan; Patricia P Katz; Jennifer L Barton; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Health Expect       Date:  2020-04-09       Impact factor: 3.377

5.  Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower.

Authors:  W Benjamin Nowell; Kelly Gavigan; Carol L Kannowski; Zhihong Cai; Theresa Hunter; Shilpa Venkatachalam; Julie Birt; Jennifer Workman; Jeffrey R Curtis
Journal:  Arthritis Res Ther       Date:  2021-02-10       Impact factor: 5.156

6.  The Relationship Between Electronic Health Record System and Performance on Quality Measures in the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry: Observational Study.

Authors:  Nevin Hammam; Zara Izadi; Jing Li; Michael Evans; Julia Kay; Stephen Shiboski; Gabriela Schmajuk; Jinoos Yazdany
Journal:  JMIR Med Inform       Date:  2021-11-12

7.  Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis.

Authors:  Howard Busch; George J Wan; John Niewoehner; Parul Houston; Yujie Su; Cassie Clinton; Mary P Panaccio
Journal:  Drugs Context       Date:  2022-03-25

8.  Disease activity correlates and functionality in patients with rheumatoid arthritis - real-world experience from a South Asian country.

Authors:  Noreen Nasir; Hafsa Majid; Ayesha Habib Khan; Safia Awan; Mohammed Mehmood Riaz
Journal:  Reumatologia       Date:  2022-07-13

9.  Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.

Authors:  Evgeniy Nasonov; Saeed Fatenejad; Eugen Feist; Mariana Ivanova; Elena Korneva; Diana G Krechikova; Aleksey L Maslyanskiy; Mikhail Samsonov; Rumen Stoilov; Elena V Zonova; Mark Genovese
Journal:  Ann Rheum Dis       Date:  2021-08-03       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.